Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study
Diabetes, Obesity and Metabolism · 2025-06 · 27 (6) · 3201-3211
DOI: 10.1111/dom.16333 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 13.03.2025. Verfasst von Michela Vergani und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin Resistance, Liver Cirrhosis, Fatty Liver. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background and aim We assessed the prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) and significant liver fibrosis in adults with type 1 diabetes mellitus (T1DM) and the association of MASLD with insulin sensitivity and continuous glucose monitoring metrics.
Methods
We consecutively enrolled 198 adults with T1DM undergoing vibration‐controlled transient elastography with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP). All participants had a continuous glucose monitoring (CGM) device. Insulin sensitivity was evaluated by estimated glucose disposal rate (eGDR). MASLD was defined as CAP ≥ 248 db/m and the presence of at least one cardiometabolic risk factor. Significant liver fibrosis was defined as LSM ≥ 7 kPa.
Results
Patients had a mean age of 56 years, mean BMI of 26.0 ± 5.9 kg/m 2 , and mean eGDR of 7.1 ± 2.3 mg/kg/min. 73 (37%) patients had MASLD (using a CAP threshold of 274 dB/m), 16 (8.1%) of whom had significant liver fibrosis. MASLD was associated with a significantly lower eGDR (beta coefficient = −0.367, 95% confidence interval −0.472 to −0.261; p < 0.001). This association remained significant, even after adjustment for age, sex, body mass index, plasma triglycerides, diabetes duration, daily insulin dose, time above the range of glucose levels, LSM and chronic kidney disease. No association was observed between MASLD and CGM‐derived metrics. These results were not different when we used a CAP threshold of 274 dB/m for diagnosing MASLD.
Conclusion
In T1DM, MASLD was inversely associated with eGDR and biomarkers of insulin resistance but not with CGM‐derived metrics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy.
- School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
- Department of Medicine, University of Verona, Verona, Italy.
- Metabolic Diseases Research Unit, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella (VR), Italy.
ORCID-Profile: Giovanni Targher, Gianluca Perseghin, Alessandro Mantovani, Stefano Ciardullo
Zitieren
APA
Vergani, M., Borella, N. D., Rizzo, M., Conti, M., Perra, S., Bianconi, E., Sani, E., Csermely, A., Grespan, E., Targher, G., Perseghin, G., Mantovani, A., & Ciardullo, S. (2025). Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study. Diabetes, Obesity and Metabolism, 27(6), 3201-3211. https://doi.org/10.1111/dom.16333
Vancouver
Vergani M, Borella ND, Rizzo M, Conti M, Perra S, Bianconi E, et al. Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study. Diabetes, Obesity and Metabolism. 2025;27(6):3201-3211. doi:10.1111/dom.16333
BibTeX
@article{Vergani2025,
author = {Vergani, Michela and Borella, Nicolò Diego and Rizzo, Mariangela and Conti, Matteo and Perra, Silvia and Bianconi, Eleonora and Sani, Elena and Csermely, Alessandro and Grespan, Elisabetta and Targher, Giovanni and Perseghin, Gianluca and Mantovani, Alessandro and Ciardullo, Stefano},
title = {Metabolic dysfunction‐associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi‐centre cross‐sectional study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {6},
pages = {3201--3211},
doi = {10.1111/dom.16333}
}
EUVIMED